×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Coronavirus | Israel | Vaccines | pfizer | netanyahu | vaccination | study

Pfizer Chose Israel for Vaccine Study Due to Netanyahu's 'Obsession'

netanyahu in a suit with israeli flag behind him
Israeli Prime Minister Benjamin Netanyahu (Abir Sultan/Getty Images)

Friday, 12 March 2021 10:43 AM

Pfizer Inc. chose Israel for a nationwide COVID-19 vaccination study, supplying enough shots to quickly inoculate the entire eligible population, after dozens of phone calls from its prime minister, sometimes in the middle of the night.

The country’s relatively small size and electronic health records that cover more than 99% of residents were two important reasons for siting the study in Israel, Pfizer Chief Executive Officer Albert Bourla said in an interview late Thursday with Israel’s Channel 12 news. But what tipped the scales in Israel’s favor was Prime Minister Benjamin Netanyahu’s persistence, which Bourla termed an “obsession.”

“He called me 30 times,” Bourla said. “He would ask me about the variants, what data we have. And I would say, ‘Prime Minister, it’s three o’clock.’ And he said, ‘No, no, don’t worry, tell me.’ Or he would call me to ask about the children, ‘I need to vaccinate the schools.’ Or to ask about pregnant women. So he convinced me, frankly, that he would be on top of it.”

Israel leads the world in pandemic vaccination after beginning its campaign in December. More than half the population has had at least one dose. The country also agreed to collect and share real-world data on how well the vaccine is working, turning its rollout into a case study for the rest of the world.

The Pfizer Inc.-BioNTech SE coronavirus vaccine blocked 94% of asymptomatic infections and stopped 97% of symptomatic cases, hospitalizations, and deaths, the companies and the country’s health ministry said in a study published on Thursday.

© Copyright 2021 Bloomberg News. All rights reserved.


GlobalTalk
Pfizer Inc. chose Israel for a nationwide COVID-19 vaccination study, supplying enough shots to quickly inoculate the entire eligible population, after dozens of phone calls from its prime minister, sometimes in the middle of the night. The country's relatively small size...
pfizer, netanyahu, vaccination, study, shots
257
2021-43-12
Friday, 12 March 2021 10:43 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved